Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
about
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patientsOptimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancerKLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer.Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering
P2860
Q33794911-DED3B2C5-49F5-4CAF-A6F2-7500E1AF6A2AQ34738849-04FE9C3D-A834-4C51-A685-3A2C628D7D62Q35032994-0EDFBF6D-380D-4489-880C-9D59EE9D1425Q35623800-3771F725-9EA2-4461-9197-19378DE694C3Q35837949-92E9BF72-19B9-4332-BC7E-DA8B16B6FD09Q36908718-A4642983-7E96-4ABB-91B5-1C0431A13BDDQ37400530-CC94407B-93F0-494D-AA05-6EA1BFE2EBFFQ37690308-01B5A56C-59A1-411E-ACDB-554A6F821403Q37952006-153308BD-069A-4FAB-B489-594D08FC3D57Q39080408-5B5B1BA2-22B4-4A71-800A-1312C2ED702AQ39201211-B1FD997A-9E13-4AA5-B615-3FB2628A5C32Q43489162-1D6D7ED8-855D-4988-A983-22EE2EE27CECQ46588877-092496EC-B037-472F-A333-258F5C4B7206Q47660938-CEE2D273-0EEC-41C7-B884-878575481426Q56888917-5EBDF34F-C84B-4955-B7DE-DAA14E4F42CA
P2860
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Prognostic value of kallikrein ...... quantitative analysis (AQUA).
@en
Prognostic value of kallikrein ...... utomated quantitative analysis
@nl
type
label
Prognostic value of kallikrein ...... quantitative analysis (AQUA).
@en
Prognostic value of kallikrein ...... utomated quantitative analysis
@nl
prefLabel
Prognostic value of kallikrein ...... quantitative analysis (AQUA).
@en
Prognostic value of kallikrein ...... utomated quantitative analysis
@nl
P2093
P2860
P50
P1433
P1476
Prognostic value of kallikrein ...... quantitative analysis (AQUA).
@en
P2093
Amanda Psyrri
Diane Kowalski
Panteleimon Kountourakis
Robert Camp
Sonia Markakis
P2860
P304
P356
10.1111/J.1349-7006.2008.00942.X
P577
2008-10-09T00:00:00Z